Related Experiment Video
Updated: Apr 16, 2026
A Fluorescence-based Protocol for Preliminary Screening of Protein Synthesis Inhibitors from Natural Sources
Published on: January 27, 2026
Parasporins as new natural anticancer agents: a review
Almas Okassov1, Armen Nersesyan, Sakae Kitada
1Scientific Center of Anti-Infectious Drugs, Almaty, Kazakhstan.
Abstract:
In 1999 Mizuki and co-authors studied for the first time the parasporal inclusion proteins extracted from B. thuringiensis strains (a Gram-positive, soil-dwelling bacterium) for cytotoxic activity against human leukaemia T-cells. Later some other proteins with this unusual property to recognize human leukemic cells were isolated from this strain of bacteria and named parasporins. At present 6 types of parasporins are identified and characterized. This review summarizes the properties of these new potentially useful antitumor agents of natural origin. Various types of parasporins possess unique cytotoxic mechanisms against cancer cells. The cytotoxic activity for cancer cells makes parasporins possible candidates for anticancer agents in clinical oncology. Recently, genetic engineering was applied for the production of parasporins and the gene responsible for the production of the proteins was expressed in E. coli. However, there are virtually no data regarding the cytotoxic (antitumor) activity of parasporins in vivo. These relatively new cytotoxic proteins warrant further investigation, especially in rodents, for possible application in clinical oncology.
Insights
Parasporins, proteins from Bacillus thuringiensis bacteria, show cytotoxic activity against human leukemia cells. These natural compounds are promising candidates for novel anticancer agents, but require further in vivo investigation.
Area of Science:
- Microbiology
- Biochemistry
- Oncology
Background:
- Bacillus thuringiensis (B. thuringiensis) bacteria produce parasporal inclusion proteins.
- Initial studies in 1999 investigated these proteins for cytotoxic activity against human leukemia T-cells.
- Six types of parasporins have been identified, exhibiting unique cytotoxic mechanisms against cancer cells.
Purpose of the Study:
- To review the properties of parasporins as potential antitumor agents.
- To highlight the cytotoxic mechanisms of parasporins against cancer cells.
- To discuss the potential application of parasporins in clinical oncology.
Main Methods:
- Literature review summarizing existing research on parasporins.
- Analysis of identified parasporin types and their characterized properties.
- Discussion of recent advancements, including genetic engineering for production.
Main Results:
- Parasporins demonstrate cytotoxic activity against human leukemic cells.
- Various parasporin types exhibit distinct cytotoxic mechanisms against cancer cells.
- Genetic engineering has enabled the expression of parasporin genes in E. coli.
Conclusions:
- Parasporins are natural compounds with significant potential as anticancer agents.
- Further in vivo studies, particularly in rodent models, are necessary to evaluate their antitumor efficacy for clinical oncology.
- The unique cytotoxic properties of parasporins warrant continued investigation for therapeutic development.
Related Concept Videos
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:15Drugs that Stabilize Microtubules
01:10Drugs that Destabilize Microtubules
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:18Cancer
01:15Anthelminthic Agents